Lakeview Health Addiction Treatment Outcomes

Below are statistics of Lakeview Health's rehab addiction treatment success versus a polled national average of facilities by Vista.

The abstinent rates for Lakeview Health’s programs at one, six, and twelve months post-treatment are higher than the normal rates of dozens of addiction treatment facilities surveyed by Vista at each of those time periods:

Abstinent vs Sampled Average

Lakeview Health (Rose & Star)

(among patients discharged between 9/18/2018 and 4/30/2024)

Vista Research Network Norm

(among adult SUD patients discharged between 7/1/2016 and 12/31/23)

It is important for context to note that Vista's norms are probably well above the average for the entire addiction treatment industry today. The reason for this is that the only treatment centers which are likely to make the significant investment in tracking their post-treatment outcomes are top-quality programs that are confident their outcomes are very good.

Successfully Completing Treatment

At one month post-treatment, 52% of the patients who successfully completed all recommended treatment reported having been abstinent since discharge. In comparison, only 30% of the patients who did not complete treatment reported being abstinent:

Lakeview Health (Rose & Star)

Abstinence at One Month – Completed Recommended Treatment

(among 1302 patients discharged between 9/18/2018 and 4/30/2024)

Abstinence at One Month – Did Not Complete Recommended Treatment

(among 236 patients discharged between 9/18/2018 and 4/30/2024)

Lakeview Health (Rose & Star)

Abstinence at Six Month – Completed Recommended Treatment

(among 1144 patients discharged between 9/18/2018 and 11/30/2023)

Abstinence at Six Month – Did not Completed Recommended Treatnment

(among 211 patients discharged between 9/18/2018 and 11/30/2023)

Lakeview Health (Rose & Star)

Abstinence at Twelve Month – Completed Recommended Treatment

(among 1033 patients discharged between 9/18/2018 and 5/31/2023)

Abstinence at Twelve Month – Did Not Complete Recommended Treatment

(among 184 patients discharged between 9/18/2018 and 5/31/2023)

Lakeview Health (Rose & Star)

Outcomes by Length of Stay

At Twelve Months Post-Treatment
(among patients discharged between 9/18/2018 and 5/31/2023)

Lakeview Health (Rose & Star)

Abstinence Rates by Primary Drug of Choice At Twelve Months Post-Treatment
(among patients discharged between 9/18/2018 and 5/31/2023)

Vista Research Network Norm

Abstinence Rates by Primary Drug of Choice At Twelve Months Post-Treatment
(among adult SUD patients discharged between 7/1/2016 and 12/31/2022)

Reduction in Severity of Co-Occurring Disorders

The percentages of patients reporting moderate to severe symptoms of co-occurring disorders decreased dramatically during treatment and remained low throughout the post-treatment year:

Lakeview Health (Rose & Star)

Patients with Moderate to Severe Depression Symptoms

(among patients who submitted surveys which were due by May 31, 2024)

Lakeview Health (Rose & Star)

Patients with Moderate to Severe Anxiety Symptoms

(among patients who submitted surveys which were due by May 31, 2024)

Lakeview Health (Rose & Star)

Patients with Moderate to Severe Trauma Symptoms

(among patients who submitted surveys which were due by May 31, 2024)

Feeling Good Overall

Lakeview Health (Rose & Star)

(among 536 patients who submitted a 12-month survey)

Good Relationship with Closest Family Members

Lakeview Health (Rose & Star)

(among 528 patients who submitted a 12-month survey)

Lakeview Health (Rose & Star)

Progress on Achieving Non-Usage-Related Goals by One Year Post-Treatment
(among 536 patients discharged between 9/18/2018 & 5/31/2023 who submitted a 12-month survey)

When reached post-treatment, most patients reported being quite satisfied with the treatment they had received at Lakeview-Rose & Star:

Patient Satisfaction with Treatment

Lakeview Health (Rose & Star)